Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the School Health topic
No spam. Unsubscribe anytime.
SB 568 modernizes school epinephrine requirements and clarifies preschool coverage
Summary
SB 568 updates California law to modern medication language, clarify that stock (unassigned) epinephrine must cover preschool programs, and align dosing/standing‑order practice; school nurses and medical societies testified in support.
Sen. [presenter] introduced SB 568, described in committee as the Epinephrine in Schools Modernization Act, accepting committee amendments to clarify medication language and explicitly include preschool programs.
Witnesses supporting the bill included school nurse Kirsten Monk (Sacramento State/California School Nurses Organization) and allergist Dr. Travis Miller (American College of Allergy, Asthma, and Immunology). Monk described operational confusion since SB 1266 (2014) and said some preschools have had difficulty obtaining standing orders or stock epinephrine because programs were not specifically covered. “Access to emergency epinephrine in case of anaphylaxis should be available to anyone, child or adult in our schools,” she said.
Dr. Miller said epinephrine remains the first‑line, life‑saving treatment for anaphylaxis and that multiple dosing strengths (0.3 mg, 0.15 mg, 0.1 mg) are available to match pediatric weight needs; he urged the committee to move SB 568 for signature. Multiple medical associations and nursing organizations also registered support. The committee voted to refer SB 568 to Appropriations for further consideration.
